Exelixis, Inc. - Common Stock (NQ:EXEL)

42.25 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 24, 2025 Add to My Watchlist

Price and Volume

Volume	259
Open	42.25
Bid (Size)	42.00 (300)
Ask (Size)	42.75 (100)
Prev. Close	42.25
Today's Range	42.25 - 42.25
52wk Range	31.90 - 49.62
Shares Outstanding	315,048,788
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

EXELIXIS INC (NASDAQ:EXEL) Presents a Compelling Value Investment Opportunity ↗

November 21, 2025

Discover EXELIXIS (EXEL), a value stock with strong profitability, zero debt, and solid growth, trading at an attractive discount to its industry peers.

Via Chartmill

Exelixis Inc (NASDAQ:EXEL) Emerges as a Top Affordable Growth Stock ↗

November 19, 2025

Exelixis (EXEL) is a GARP stock with strong earnings growth, a reasonable valuation, and a debt-free balance sheet.

Via Chartmill

Performance

YTD	+24.5%	+24.5%
1 Month	+5.7%	+5.7%
3 Month	+11.5%	+11.5%
6 Month	-1.9%	-1.9%
1 Year	+16.1%	+16.1%

More News

S&P 500 Surges as Congress Nears End to Protracted Government Shutdown

November 10, 2025

Via MarketMinute

Global Markets Rally on Hopes for US Government Shutdown Resolution

November 10, 2025

Via MarketMinute

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally

November 07, 2025

Via MarketMinute

Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in November

November 06, 2025

From Exelixis, Inc.

Via Business Wire

Exelixis Announces Third Quarter 2025 Financial Results and Provides Corporate Update

November 04, 2025

From Exelixis, Inc.

Via Business Wire

Preview: Exelixis's Earnings ↗

November 03, 2025

Via Benzinga

17 Analysts Have This To Say About Exelixis ↗

September 17, 2025

Via Benzinga

What's Driving the Market Sentiment Around Exelixis Inc? ↗

October 30, 2025

Via Benzinga

Merck's New Cancer Therapy Combo Shows Significant Edge Over Rivals In Renal Cancer ↗

October 28, 2025

Via Benzinga

EXELIXIS INC (NASDAQ:EXEL) Represents an Affordable Growth Opportunity ↗

October 28, 2025

Via Chartmill

Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

October 21, 2025

From Exelixis, Inc.

Via Business Wire

This Nextracker Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗

October 21, 2025

Via Benzinga

Top 3 Health Care Stocks You'll Regret Missing In October ↗

October 21, 2025

Via Benzinga

Exelixis Stock Falls After Phase 3 Colorectal Cancer Trial Shows Mixed Results ↗

October 20, 2025

Via Benzinga

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

October 20, 2025

Via Benzinga

Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket ↗

October 20, 2025

Via Benzinga

Exelixis Announces Detailed Results from Phase 3 STELLAR-303 Pivotal Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Metastatic Colorectal Cancer Presented at ESMO 2025 and Published in The Lancet

October 20, 2025

From Exelixis, Inc.

Via Business Wire

Exelixis Announces Results from Subgroup Analysis of CABINET Phase 3 Pivotal Trial Evaluating CABOMETYX® (cabozantinib) in Advanced Lung and Thymic Neuroendocrine Tumors at ESMO 2025

October 18, 2025

From Exelixis, Inc.

Via Business Wire

The Ultimate Biotech Stock to Buy With $50 Right Now ↗

October 14, 2025

Via The Motley Fool

EXELIXIS INC (NASDAQ:EXEL) Identified as a Quality Value Stock by Fundamental Screening ↗

October 07, 2025

Via Chartmill

EXELIXIS INC (NASDAQ:EXEL) Stands Out as an Affordable Growth Stock ↗

October 04, 2025

Via Chartmill

Prediction: These 2 Under-the-Radar Stocks Could Beat the Market in the Next 5 Years ↗

September 30, 2025

Via The Motley Fool

Frequently Asked Questions

Is Exelixis, Inc. - Common Stock publicly traded?

Yes, Exelixis, Inc. - Common Stock is publicly traded.

What exchange does Exelixis, Inc. - Common Stock trade on?

Exelixis, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Exelixis, Inc. - Common Stock?

The ticker symbol for Exelixis, Inc. - Common Stock is EXEL on the Nasdaq Stock Market

What is the current price of Exelixis, Inc. - Common Stock?

The current price of Exelixis, Inc. - Common Stock is 42.25

When was Exelixis, Inc. - Common Stock last traded?

The last trade of Exelixis, Inc. - Common Stock was at 11/24/25 04:00 PM ET

What is the market capitalization of Exelixis, Inc. - Common Stock?

The market capitalization of Exelixis, Inc. - Common Stock is 13.31B

How many shares of Exelixis, Inc. - Common Stock are outstanding?

Exelixis, Inc. - Common Stock has 13B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.